Elo-Mel Paediatric

Elo-Mel Paediatric is an intravenous electrolyte solution designed for pediatric use. It contains essential minerals like magnesium, potassium, sodium, and calcium to support hydration and electrolyte balance. This solution is commonly used in clinical settings for children requiring fluid and electrolyte replenishment.

Elo-Mel Paediatric is primarily used to replenish electrolytes and fluids in pediatric patients. It is often administered to children who are dehydrated or have imbalances in their electrolyte levels. The solution contains magnesium chloride hexahydrate, potassium chloride, sodium chloride, and calcium chloride dihydrate, which are essential for maintaining proper bodily functions. This makes it a valuable tool in managing conditions that require fluid and electrolyte replacement.

When administered intravenously, Elo-Mel Paediatric helps to restore and maintain the body's electrolyte balance. This can lead to improved hydration and overall well-being. The solution is designed to be gentle on the pediatric system, ensuring that the necessary minerals are delivered effectively. Common effects include improved energy levels and better fluid balance in the body.

Elo-Mel Paediatric should be used under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration guidelines to avoid any potential adverse effects. Patients with certain medical conditions or allergies should inform their healthcare provider before using this solution. Always ensure that the solution is stored and handled according to the manufacturer's instructions.

Elo-Mel Paediatric may interact with certain medications or supplements. It is important to inform your healthcare provider about all the medications you are taking to avoid any potential interactions. Additionally, the solution should be used with caution in patients who are taking diuretics or other medications that affect electrolyte levels. Always consult with a healthcare professional before starting any new treatment.